Repetitive Transcranial Magnetic Stimulation (rTMS) Modulates Thyroid Hormones Level and Cognition in the Recovery Stage of Stroke Patients with Cognitive Dysfunction

23 October 2021: Clinical Research

Hong Li ^1AE* , Jiang Ma ^1AE** , Jun Zhang ^2C , Wan-Ying Shi ^3F , Hao-Nan Mei ^2B , Yan Xing ^1C

DOI: 10.12659/MSM.931914

Med Sci Monit 2021; 27:e931914

Table 5 Comparison of pre- and post-treatment levels of thyroid hormones and TSH in the 2 groups.

Group	Time	T3 (nmol/L)	T4 (nmol/L)	FT3 (pmol/L)	FT4 (pmol/L)	TSH (uIU/mL)
rTMS (n=33)	Pre	1.11±0.25	116.92±22.97	4.01±0.67	12.29±1.94	2.02±1.05
	Post	1.31±0.18	116.62±21.18	4.54±0.66	11.93±2.38	2.91±1.16
	t	6.114	−0.072	4.295	−0.887	5.324
	P		0.943		0.382
Sham (n=32)	Pre	1.11±0.19	124.19±20.29	4.02±0.66	11.94±2.17	2.02±1.18
	Post	1.18±0.24	119.02±20.84	4.18±0.68	11.32±2.02	2.25±1.25
	t	2.066	−1.838	2.058	−1.677	1.920
	P	0.047	0.076	0.048	0.104	0.064
Data presented as mean±standard deviation. rTMS – repetitive transcranial magnetic stimulation.